Gu idance for Industry IRB Rev ie w of StandA lone HIPAA Au thorizations Under FDA Regu lations FINAL GUIDANCE This guidance is being distributed for immediate implementation - PDF document

Download presentation
Gu idance for Industry IRB Rev ie w of StandA lone HIPAA Au thorizations Under FDA Regu lations FINAL GUIDANCE This guidance is being distributed for immediate implementation
Gu idance for Industry IRB Rev ie w of StandA lone HIPAA Au thorizations Under FDA Regu lations FINAL GUIDANCE This guidance is being distributed for immediate implementation

Gu idance for Industry IRB Rev ie w of StandA lone HIPAA Au thorizations Under FDA Regu lations FINAL GUIDANCE This guidance is being distributed for immediate implementation - Description

FDA is issuing this guidance for immediate implementation in accordance with 21 CFR 10115g3 without seeking prior comment because the agency has determined that prior public participation would not be feasible or appropriate FDA made this determinat ID: 7302 Download Pdf

Tags

FDA issuing this

Embed / Share - Gu idance for Industry IRB Rev ie w of StandA lone HIPAA Au thorizations Under FDA Regu lations FINAL GUIDANCE This guidance is being distributed for immediate implementation

Presentation on theme: "Gu idance for Industry IRB Rev ie w of StandA lone HIPAA Au thorizations Under FDA Regu lations FINAL GUIDANCE This guidance is being distributed for immediate implementation"— Presentation transcript

pdf

Shom More....
By: briana-ranney
Views: 84
Type: Public

Download Section

Please download the presentation after appearing the download area.

Download Pdf - The PPT/PDF document "Gu idance for Industry IRB Rev ie w of S..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Try DocSlides online tool for compressing your PDF Files Try Now

Related Documents

Guidance for Industry How to Comply with the Pediatric Research Equity Act DRAFT GUIDANCE This guidance document is being distributed for comment purposes only
Guidance for Industry How to Comply with the Pediatric Research Equity Act DRAFT GUIDANCE This guidance document is being distributed for comment purposes only PDF document
Guidance for Industry How to Comply with the Pediatric Research Equity Act DRAFT GUIDANCE This guidance document is being distributed for comment purposes only PDF document
pdf 328 views
Guidance for Industry ANDA Submissions Prior Approval Supplements Under GDUFA DRAFT GUIDANCE This guidance document is being distributed for comment purposes only
Guidance for Industry ANDA Submissions Prior Approval Supplements Under GDUFA DRAFT GUIDANCE This guidance document is being distributed for comment purposes only PDF document
Guidance for Industry ANDA Submissions Prior Approval Supplements Under GDUFA DRAFT GUIDANCE This guidance document is being distributed for comment purposes only PDF document
pdf 338 views
Guidance for Industry Distributing Scientific and Medical Publications on Unapproved New Uses Recommended Practices REVISED DRAFT GUIDANCE This guidance document is being distributed for comment purpo
Guidance for Industry Distributing Scientific and Medical Publications on Unapproved New Uses Recommended Practices REVISED DRAFT GUIDANCE This guidance document is being distributed for comment purpo PDF document
Guidance for Industry Distributing Scientific and Medical Publications on Unapproved New Uses Recommended Practices REVISED DRAFT GUIDANCE This guidance document is being distributed for comment purpo PDF document
pdf 144 views
ANDA Submissions Refuse to Receive for Lack of Proper Justification of Impurity Limits Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only
ANDA Submissions Refuse to Receive for Lack of Proper Justification of Impurity Limits Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only PDF document
ANDA Submissions Refuse to Receive for Lack of Proper Justification of Impurity Limits Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only PDF document
pdf 272 views
Uniform Guidance Crosswalk from Final Guidance to Existing Guidance A A A A A A A A Section In OMB Uniform Guidance Cost Principles Audit and Administrative Requirements for Federal Awards Or
Uniform Guidance Crosswalk from Final Guidance to Existing Guidance A A A A A A A A Section In OMB Uniform Guidance Cost Principles Audit and Administrative Requirements for Federal Awards Or PDF document
Uniform Guidance Crosswalk from Final Guidance to Existing Guidance A A A A A A A A Section In OMB Uniform Guidance Cost Principles Audit and Administrative Requirements for Federal Awards Or PDF document
pdf 480 views
Guidance for Industry Regulation of Human Cells Tissues and Cellular and TissueBased Products HCTPs Small Entity Compliance Guide This guidance is for immediate implementation
Guidance for Industry Regulation of Human Cells Tissues and Cellular and TissueBased Products HCTPs Small Entity Compliance Guide This guidance is for immediate implementation PDF document
Guidance for Industry Regulation of Human Cells Tissues and Cellular and TissueBased Products HCTPs Small Entity Compliance Guide This guidance is for immediate implementation PDF document
pdf 336 views
Informed Consent Information Sheet Guidance for IRBs Clinical Investigators and Sponsors DRAFT GUIDANCE This guidance document is being distributed for comment purposes only
Informed Consent Information Sheet Guidance for IRBs Clinical Investigators and Sponsors DRAFT GUIDANCE This guidance document is being distributed for comment purposes only PDF document
Informed Consent Information Sheet Guidance for IRBs Clinical Investigators and Sponsors DRAFT GUIDANCE This guidance document is being distributed for comment purposes only PDF document
pdf 233 views
Guidance for Industry and FDA Staff Commercially Distributed Analyte Specific Reagents ASRs Frequently Asked Questions Document issued on September The draft of this guidance docume nt was released
Guidance for Industry and FDA Staff Commercially Distributed Analyte Specific Reagents ASRs Frequently Asked Questions Document issued on September The draft of this guidance docume nt was released PDF document
Guidance for Industry and FDA Staff Commercially Distributed Analyte Specific Reagents ASRs Frequently Asked Questions Document issued on September The draft of this guidance docume nt was released PDF document
pdf 178 views
Contains Nonbinding Recommendations DraftNot for Implementation Guidance for Industry Cosmetic Good Manufacturing Practices Draft Guidance Additional copies are available from Office of Cosmetics and
Contains Nonbinding Recommendations DraftNot for Implementation Guidance for Industry Cosmetic Good Manufacturing Practices Draft Guidance Additional copies are available from Office of Cosmetics and PDF document
Contains Nonbinding Recommendations DraftNot for Implementation Guidance for Industry Cosmetic Good Manufacturing Practices Draft Guidance Additional copies are available from Office of Cosmetics and PDF document
pdf 135 views
Guidance for Industry Concerns Related to the use of Clove Oil as an Anesthetic for Fish This version of the guidance replaces the ver sion that was made available in June
Guidance for Industry Concerns Related to the use of Clove Oil as an Anesthetic for Fish This version of the guidance replaces the ver sion that was made available in June PDF document
Guidance for Industry Concerns Related to the use of Clove Oil as an Anesthetic for Fish This version of the guidance replaces the ver sion that was made available in June PDF document
pdf 154 views